Clinical Trials Browser

Neurofibromatosis 2

NCT03095248 2025-04-22

SEL-TH-1601

Phase 2 Terminated

10 enrolled 9 charts

CNS

Ependymoma, Glioma, Meningioma, Neuroma, Acoustic, Neurofibromatosis 2

NCT02831257 2022-06-13

AZD2014 In NF2 Patients With Progressive or Symptomatic Meningiomas

Phase 2 Completed

18 enrolled 13 charts

CNS

Meningioma, Neurofibromatosis 2

NCT02129647 2021-12-01

Study of Axitinib in Patients With Neurofibromatosis Type 2 and Progressive Vestibular Schwannomas

Phase 2 Completed

13 enrolled 7 charts

CNS

Neuroma, Acoustic, Neurofibromatosis 2

NCT01767792 2021-02-12

Phase 2 Study of Bevacizumab in Children and Young Adults With NF 2 and Progressive Vestibular Schwannomas

Phase 2 Completed

22 enrolled 14 charts

CNS

Neurofibromatosis 2

NCT01125046 2021-01-22

Bevacizumab in Treating Patients With Recurrent or Progressive Meningiomas

Phase 2 Completed

50 enrolled 13 charts

CNS

Brain Neoplasms, Ependymoma, Meningioma, Neurofibromatosis 1, Neuroma, Acoustic, Neurofibromatosis 2

NCT01207687 2018-08-27

Bevacizumab for Symptomatic Vestibular Schwannoma in Neurofibromatosis Type 2 (NF2)

Phase 2 Completed

14 enrolled 28 charts

CNS

Neuroma, Acoustic, Neurofibromatosis 2

NCT01419639 2017-07-18

Phase II Study of Everolimus (RAD001) in Children and Adults With Neurofibromatosis Type 2

Phase 2 Completed

10 enrolled 4 charts

CNS

Ependymoma, Meningioma, Neurofibromatosis 2

NCT00973739 2016-03-22

Lapatinib Study for Children and Adults With Neurofibromatosis Type 2 (NF2) and NF2-Related Tumors

Phase 2 Completed

21 enrolled 8 charts

CNS

Neurilemmoma, Neuroma, Acoustic, Neurofibromatosis 2

NCT00589784 2016-01-25

Phase II Trial of Sunitinib (SU011248) in Patients With Recurrent or Inoperable Meningioma

Phase 2 Completed

50 enrolled 6 charts

CNS

Brain Neoplasms, Meningioma, Neurofibromatosis 1, Neurofibromatosis 2, Central Nervous System Neoplasms, Neurofibromatoses, Hemangioblastoma

Clinical Trials

NF110

SEL-TH-1601

AZD2014 In NF2 Patients With Progressive or Symptomatic Meningiomas

Study of Axitinib in Patients With Neurofibromatosis Type 2 and Progressive Vestibular Schwannomas

Phase 2 Study of Bevacizumab in Children and Young Adults With NF 2 and Progressive Vestibular Schwannomas

Bevacizumab in Treating Patients With Recurrent or Progressive Meningiomas

Bevacizumab for Symptomatic Vestibular Schwannoma in Neurofibromatosis Type 2 (NF2)

Phase II Study of Everolimus (RAD001) in Children and Adults With Neurofibromatosis Type 2

Lapatinib Study for Children and Adults With Neurofibromatosis Type 2 (NF2) and NF2-Related Tumors

Phase II Trial of Sunitinib (SU011248) in Patients With Recurrent or Inoperable Meningioma